163 related articles for article (PubMed ID: 19622716)
41. Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis.
Kourlaba G; Fragoulakis V; Maniadakis N
Appl Health Econ Health Policy; 2012 Jul; 10(4):261-71. PubMed ID: 22667992
[TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial.
Majumdar SR; Lier DA; Leslie WD
J Clin Endocrinol Metab; 2013 May; 98(5):1991-2000. PubMed ID: 23596140
[TBL] [Abstract][Full Text] [Related]
43. Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study.
Gaede P; Valentine WJ; Palmer AJ; Tucker DM; Lammert M; Parving HH; Pedersen O
Diabetes Care; 2008 Aug; 31(8):1510-5. PubMed ID: 18443195
[TBL] [Abstract][Full Text] [Related]
44. Cost-effectiveness analysis of a community health worker intervention for low-income Hispanic adults with diabetes.
Brown HS; Wilson KJ; Pagán JA; Arcari CM; Martinez M; Smith K; Reininger B
Prev Chronic Dis; 2012; 9():E140. PubMed ID: 22916995
[TBL] [Abstract][Full Text] [Related]
45. Delivering Diabetes Education through Nurse-Led Telecoaching. Cost-Effectiveness Analysis.
Odnoletkova I; Ramaekers D; Nobels F; Goderis G; Aertgeerts B; Annemans L
PLoS One; 2016; 11(10):e0163997. PubMed ID: 27727281
[TBL] [Abstract][Full Text] [Related]
46. Five-year cost-effectiveness of the Patient Empowerment Programme (PEP) for type 2 diabetes mellitus in primary care.
Lian J; McGhee SM; So C; Chau J; Wong CKH; Wong WCW; Lam CLK
Diabetes Obes Metab; 2017 Sep; 19(9):1312-1316. PubMed ID: 28230312
[TBL] [Abstract][Full Text] [Related]
47. Are lifestyle interventions in primary care cost-effective?--An analysis based on a Markov model, differences-in-differences approach and the Swedish Björknäs study.
Saha S; Carlsson KS; Gerdtham UG; Eriksson MK; Hagberg L; Eliasson M; Johansson P
PLoS One; 2013; 8(11):e80672. PubMed ID: 24244703
[TBL] [Abstract][Full Text] [Related]
48. Long-term cost-effectiveness of a Patient Empowerment Programme for type 2 diabetes mellitus in primary care.
Lian J; McGhee SM; So C; Chau J; Wong CKH; Wong WCW; Lam CLK
Diabetes Obes Metab; 2019 Jan; 21(1):73-83. PubMed ID: 30058268
[TBL] [Abstract][Full Text] [Related]
49. Cost-effectiveness of alternative thresholds of the fasting plasma glucose test to identify the target population for type 2 diabetes prevention in adults aged ≥45 years.
Zhuo X; Zhang P; Kahn HS; Gregg EW
Diabetes Care; 2013 Dec; 36(12):3992-8. PubMed ID: 24135386
[TBL] [Abstract][Full Text] [Related]
50. The Robert Wood Johnson Foundation Diabetes Initiative: demonstration projects emphasizing self-management.
Fisher EB; Brownson CA; O'Toole ML; Shetty G; Anwuri VV; Fazzone P; Housemann RA; Hampton AD; Kamerow DB; McCormack LA; Burton JA; Orleans CT; Bazzarre TL
Diabetes Educ; 2007; 33(1):83-4, 86-8, 91-2, passim. PubMed ID: 17272795
[TBL] [Abstract][Full Text] [Related]
51. Cost-effectiveness of a shared computerized decision support system for diabetes linked to electronic medical records.
O'Reilly D; Holbrook A; Blackhouse G; Troyan S; Goeree R
J Am Med Inform Assoc; 2012; 19(3):341-5. PubMed ID: 22052900
[TBL] [Abstract][Full Text] [Related]
52. Cost-Effectiveness Analysis of the Self-Management Program for Thai Patients with Metabolic Syndrome.
Sakulsupsiri A; Sakthong P; Winit-Watjana W
Value Health Reg Issues; 2016 May; 9():28-35. PubMed ID: 27881256
[TBL] [Abstract][Full Text] [Related]
53. Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life.
Nguyen E; Coleman CI; Kohn CG; Weeda ER
Int J Cardiol; 2018 Dec; 273():34-38. PubMed ID: 30266352
[TBL] [Abstract][Full Text] [Related]
54. Cost effectiveness of primary care referral to a commercial provider for weight loss treatment, relative to standard care: a modelled lifetime analysis.
Fuller NR; Carter H; Schofield D; Hauner H; Jebb SA; Colagiuri S; Caterson ID
Int J Obes (Lond); 2014 Aug; 38(8):1104-9. PubMed ID: 24301133
[TBL] [Abstract][Full Text] [Related]
55. Cost-Effectiveness of a Technology-Enhanced Diabetes Care Management Program in Mexico.
Gilmer T; Burgos JL; Anzaldo-Campos MC; Vargas-Ojeda A
Value Health Reg Issues; 2019 Dec; 20():41-46. PubMed ID: 30856542
[TBL] [Abstract][Full Text] [Related]
56. Systematic review on the cost-effectiveness of self-management education programme for type 2 diabetes mellitus.
Lian JX; McGhee SM; Chau J; Wong CKH; Lam CLK; Wong WCW
Diabetes Res Clin Pract; 2017 May; 127():21-34. PubMed ID: 28315575
[TBL] [Abstract][Full Text] [Related]
57. A New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, and Cost-Effectiveness.
Hoerger TJ; Hilscher R; Neuwahl S; Kaufmann MB; Shao H; Laxy M; Cheng YJ; Benoit S; Chen H; Anderson A; Craven T; Yang W; Cintina I; Staimez L; Zhang P;
Value Health; 2023 Sep; 26(9):1372-1380. PubMed ID: 37236396
[TBL] [Abstract][Full Text] [Related]
58. Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data.
Leal J; Reed SD; Patel R; Rivero-Arias O; Li Y; Schulman KA; Califf RM; Holman RR; Gray AM
Diabetes Care; 2020 Oct; 43(10):2485-2492. PubMed ID: 32796009
[TBL] [Abstract][Full Text] [Related]
59. Cost-Effectiveness of Telemonitoring and Self-Monitoring of Blood Pressure for Antihypertensive Titration in Primary Care (TASMINH4).
Monahan M; Jowett S; Nickless A; Franssen M; Grant S; Greenfield S; Hobbs FDR; Hodgkinson J; Mant J; McManus RJ
Hypertension; 2019 Jun; 73(6):1231-1239. PubMed ID: 31067190
[TBL] [Abstract][Full Text] [Related]
60. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis.
Keating CL; Dixon JB; Moodie ML; Peeters A; Bulfone L; Maglianno DJ; O'Brien PE
Diabetes Care; 2009 Apr; 32(4):567-74. PubMed ID: 19171720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
